![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi6FT660K5n8UW49nIbFodysSPUdkDd2ZoM2nfgfF1VYg-NrSxriwxaMhzTs4BpUKvjxRGj6sk6VhwIHxkdv4A0EsYT52-Llk93XE5MJBES1oOidl500FNcuM9pXpGX8nrAbbdxfivvdw0/s320/domainnamelogo.jpg)
Human medicines - Orphan medicinal products
Summaries of opinion on orphan designation
Please use the mail box to comment on summaries of opinion on orphan designation. Please note, however, that the EMEA will not answer individual e-mails received.
Note: Draft status is awarded to a title when the document is pending comments from patients' representative organisation
Click on a column heading to sort alphabetically, or by positive/negative opinion, or by document publication date
abrir aquí para acceder al documento general y desde allí a las moléculas de interés:
European Medicines Agency - Human Medicines - Orphan medicinal products - Summaries of opinion on orphan designation
No hay comentarios:
Publicar un comentario